Alnylam Pharmaceuticals
ALNY
#587
Rank
C$48.36 B
Marketcap
$374.99
Share price
-1.46%
Change (1 day)
63.90%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company